YiChang HEC ChangJiang Pharmaceutical Co., Ltd. (HKG:1558)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
12.48
-0.18 (-1.42%)
Apr 24, 2025, 4:08 PM HKT
4.35%
Market Cap 11.14B
Revenue (ttm) 3.96B
Net Income (ttm) 513.69M
Shares Out 879.97M
EPS (ttm) 0.58
PE Ratio 21.69
Forward PE 6.60
Dividend n/a
Ex-Dividend Date n/a
Volume 12,198,826
Average Volume 8,885,152
Open 12.78
Previous Close 12.66
Day's Range 12.26 - 13.04
52-Week Range 7.92 - 13.30
Beta -0.13
RSI 77.16
Earnings Date May 30, 2025

About HKG:1558

YiChang HEC ChangJiang Pharmaceutical Co., Ltd. develops, manufactures, sells, and markets pharmaceutical products in the therapeutic areas of anti-infection, endocrine and metabolic, and other diseases in the People’s Republic of China. It manufactures and sells active pharmaceutical ingredients; researches and develops pharmaceutical products, and medical devices and drugs, as well as biotechnology; and provides marketing and medical consulting services. The company sells its products to hospitals and medical institutions through a network of... [Read more]

Sector Healthcare
Founded 2001
Employees 4,861
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 1558
Full Company Profile

Financial Performance

In 2024, HKG:1558's revenue was 3.72 billion, a decrease of -40.84% compared to the previous year's 6.29 billion. Earnings were 482.71 million, a decrease of -75.78%.

Financial numbers in CNY Financial Statements

News

There is no news available yet.